Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 31, 2025
Reporting period
Not applicable
Filed with the SEC
Nov 3, 2025
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000313143-25-000064
Filed / recorded
Nov 3, 2025, 9:19 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
HAEMONETICS CORP
Issuer CIK
313143
Ticker
HAE
Reporting person
Roy Galvin
Relationship
Officer
Officer title
EVP, Chief Commercial Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 31, 2025
Transaction code
F
Shares / units
145
Price per share
$50.01
Acquired / disposed
Disposed (D)
Shares owned after
12,811
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
This number includes unvested RSUs previously reported as well as 24 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2025.